Caffeine impairs intramuscular energy balance in patients susceptible to malignant hyperthermia

被引:5
|
作者
Textor, Z
Beer, M
Anetseder, M
Köstler, H
Kagerbauer, E
Kenn, W
Hahn, D
Roewer, N
机构
[1] Univ Wurzburg, Dept Anesthesiol, D-97080 Wurzburg, Germany
[2] Univ Wurzburg, Dept Radiol, Wurzburg, Germany
关键词
caffeine; diagnosis; energy metabolism; malignant hyperthermia; P-31-MRS;
D O I
10.1002/mus.10445
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Malignant hyperthermia (MH) is a metabolic myopathy with an abnormal release of calcium by the sarcoplasmic reticulum (SR), triggered by volatile anesthetics and succinylcholine. Similarly, caffeine enhances Ca2+ release by the SR in vitro. In a prospective, randomized study, high-energy phosphates were studied by intramuscular 31-phosphorus magnetic resonance spectroscopy (P-31-MRS) in 10 MH-susceptible (MHS) and 7 MH-nonsusceptible (MHN) subjects before and after injection of 0.5 ml caffeine (20 mM). Intramuscular energy balance, measured by the ratios of P-i/PCr and P-i/(gamma)-ATP, did not differ between MHS and MHN patients before and after intramuscular caffeine injection. However, within each group, P-i/PCr and P-i/(gamma)-ATP increased significantly only in the MHS group. Intramuscular caffeine injection seemed to impair the metabolic balance in MHS individuals. This may reflect a local calcium overload leading to consumption of high-energy phosphates and increase of inorganic phosphate. Intramuscular stimulation by caffeine and P-31-MRS may provide a valuable tool to investigate MH-related metabolic disturbances.
引用
收藏
页码:353 / 358
页数:6
相关论文
共 50 条
  • [31] Dantrolene in malignant hyperthermia (MH)-susceptible patients with exaggerated exercise stress
    Gronert, GA
    ANESTHESIOLOGY, 2000, 93 (03) : 905 - 905
  • [33] Preparing a new generation anaesthetic machine for patients susceptible to malignant hyperthermia
    Schönell, LHB
    Sims, C
    Bulsara, M
    ANAESTHESIA AND INTENSIVE CARE, 2003, 31 (01) : 58 - 62
  • [34] Preparation of the siemens KION anesthetic machine for patients susceptible to malignant hyperthermia
    Petroz, GC
    Lerman, J
    ANESTHESIOLOGY, 2002, 96 (04) : 941 - 946
  • [35] SAFETY OF AMIDE LOCAL-ANESTHETICS IN PATIENTS SUSCEPTIBLE TO MALIGNANT HYPERTHERMIA
    DERSHWITZ, M
    RYAN, JF
    GURALNICK, W
    JOURNAL OF THE AMERICAN DENTAL ASSOCIATION, 1989, 118 (03): : 276 - 280
  • [36] Pathological findings in muscle from malignant hyperthermia-susceptible patients
    Ibarra M, Carlos A.
    Malicdan, May C.
    Wu, Shiwen
    Murayama, Kumiko
    Ichihara, Yasuko
    Kikuchi, Hirosato
    Noguchi, Satoru
    Hayashi, Yukiko
    Nonaka, Ikuya
    Nishino, Ichizo
    NEUROMUSCULAR DISORDERS, 2006, 16 : S149 - S149
  • [37] Nonimmobilizers do not cause muscle contractures in patients susceptible to malignant hyperthermia
    Kindler, CH
    MOLECULAR AND BASIC MECHANISMS OF ANESTHESIA, 2002, : 299 - 305
  • [38] USE OF ATRACURIUM AND GLYCOPYRROLATE DURING ANESTHESIA OF PATIENTS SUSCEPTIBLE TO MALIGNANT HYPERTHERMIA
    ORDING, H
    NIELSEN, VG
    ACTA ANAESTHESIOLOGICA SCANDINAVICA, 1985, 29 : 64 - 64
  • [39] THE USE OF AMIDE LOCAL-ANESTHETICS IN PATIENTS SUSCEPTIBLE TO MALIGNANT HYPERTHERMIA
    MINASIAN, A
    YAGIELA, JA
    ORAL SURGERY ORAL MEDICINE ORAL PATHOLOGY ORAL RADIOLOGY AND ENDODONTICS, 1988, 66 (04): : 405 - 415
  • [40] Malignant Hyperthermia in Canada: Characteristics of Index Anesthetics in 129 Malignant Hyperthermia Susceptible Probands
    Riazi, Sheila
    Larach, Marilyn Green
    Hu, Charles
    Wijeysundera, Duminda
    Massey, Christine
    Kraeva, Natalia
    ANESTHESIA AND ANALGESIA, 2014, 118 (02): : 381 - 387